• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Flowflex SARSCoV2 Antigen Rapid Test (SelfTesting), CE marked

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Flowflex SARSCoV2 Antigen Rapid Test (SelfTesting), CE markedsee related information
Date Initiated by FirmJanuary 09, 2022
Create DateApril 15, 2022
Recall Status1 Open3, Classified
Recall NumberZ-0945-2022
Recall Event ID 89755
Product Classification Coronavirus antigen detection test system. - Product Code QKP
ProductFlowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked
Code Information Lots: COV1080201, COV1105014
FEI Number 3002829675
Recalling Firm/
Manufacturer
Acon Biotech (Hangzhou) Co., Ltd.
398 Tianmushan Road
Hangzhou China
For Additional Information Contact
011 86 858 200
Manufacturer Reason
for Recall
Non-EUA authorized, CE marked, SARS-CoV-2 antigen rapid test kits are being recalled from the U.S. market because use may lead to inaccurate test results, including false negative or false positive test results.
FDA Determined
Cause 2
No Marketing Application
ActionOn 04/04/22, recall notices were sent to distributor customers who were asked to do the following: If you may have further distributed this product, please identify your customers and notify them at once of this product correction. Your notification to your customers may be enhanced by including a copy of this correction notification letter. This correction should be carried out to the consumer/user level in U.S. Complete and return the response form to the recalling firm. Customers with additional questions were encouraged to contact Denice Dong, Denice.Dong@aconlab.com.cn Additional instructions in a press release were provided to address affected non-EUA devices, of unknown quantity, that may have entered the U.S. market. It is recommended to stop use and dispose of affected devices in the U.S. market: https://www.aconlabs.com/news/
Quantity in Commerce303,760
DistributionUS: MD, PA International Distribution to countries of: Hungary and China.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
-
-